Chip-based human organs to revolutionize drug development

Researchers at Harvard’s Wyss Institute are developing microchips comprising the cells and functionality of human organs. These organs-on-a-chip represent an advance that could prove revolutionary for pharmaceutical companies who spend billions of dollars testing new drugs in controversial – and often ineffective – animal trials. Reuters’ Ben Gruber reports.